Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -726.07 Million | -653.91 Million | -604.67 Million | -609.95 Million | -460.3 Million | -237.66 Million |
| Net Income | -932.86 Million | -887.17 Million | -832.24 Million | -675.44 Million | -1.48 Billion | -346.9 Million |
| Depreciation & Amortization | 93.19 Million | 62.91 Million | 28.32 Million | 27.42 Million | 26.43 Million | 18.46 Million |
| Deferred income taxes | -4.82 Million | -8.75 Million | -72.02 Million | -16.27 Million | 31.38 Million | -11.39 Million |
| Stock-based compensation | 31.5 Million | 22.1 Million | 46.97 Million | 74.02 Million | 70.82 Million | 27.57 Million |
| Change in working capital | -9.14 Million | 104.41 Million | 189.65 Million | -47.73 Million | 11.14 Million | 27.07 Million |
| Other non-cash items | 96.05 Million | 52.58 Million | 34.64 Million | 28.04 Million | 882.22 Million | 47.52 Million |
| Investing Cash Flow | 21.92 Million | -384.61 Million | -466.52 Million | -107.36 Million | -201.33 Million | 292.8 Million |
| Investments in PPE | -56.84 Million | -236.96 Million | -436.62 Million | -251.47 Million | -81.41 Million | -49.46 Million |
| Acquisitions | -20 Million | -20 Million | -36.2 Million | -1.55 Million | -3.96 Million | -33.37 Million |
| Investment purchases | - | -130 Million | -1.78 Billion | -2.17 Billion | -1.8 Billion | -507.71 Million |
| Sales/Maturities of investments | - | 33.67 Million | 1.78 Billion | 2.17 Billion | 1.82 Billion | 883.35 Million |
| Other Investing Activities | 98.76 Million | -31.32 Million | 335 Thousand | 141.07 Million | -135.56 Million | 375.64 Million |
| Financing Cash Flow | 368.75 Million | 619.26 Million | 1.78 Billion | 1.04 Billion | 442.36 Million | 860.16 Million |
| Debt repayment | -956.09 Million | -54.5 Million | -51.15 Million | -95 Million | -35 Million | -50 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.92 Million | -26.77 Million | -25.87 Million | - | - | -75.59 Million |
| Common Stock Issuance | 470.08 Million | 19 Thousand | 1.3 Billion | 634.21 Million | 432.27 Million | 15 Thousand |
| Other Financing Activities | 10.29 Million | 700.52 Million | 557.76 Million | 500.78 Million | 45.08 Million | 910.14 Million |
| Accounts receivables | -91.53 Million | -388 Thousand | -53.96 Million | - | - | - |
| Accounts payables | 91.53 Million | 388 Thousand | 53.96 Million | - | - | - |
| Inventory | -6.71 Million | -5.51 Million | -3.93 Million | - | - | - |
| Other working capital | -2.42 Million | 109.93 Million | 193.58 Million | -47.73 Million | 11.14 Million | 14.74 Million |
| Cash at beginning of period | 1.34 Billion | 1.7 Billion | 1.01 Billion | 738.98 Million | 957.08 Million | 14.82 Million |
| Cash at end of period | 1.03 Billion | 1.34 Billion | 1.7 Billion | 1.01 Billion | 738.98 Million | 957.08 Million |
| Capital Expenditure | -56.84 Million | -236.96 Million | -436.62 Million | -251.47 Million | -81.41 Million | -49.46 Million |
| Effect of forex changes on cash | 27.81 Million | 58.01 Million | -23.27 Million | -41.68 Million | 1.17 Million | 26.96 Million |
| Net cash flow / Change in cash | -307.59 Million | -361.24 Million | 686.9 Million | 280.99 Million | -218.1 Million | 942.26 Million |
| Free Cash Flow | -782.92 Million | -890.87 Million | -1.04 Billion | -861.43 Million | -541.72 Million | -287.12 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -932.86 Million | -72.37 Million | -58.04 Million | -887.17 Million | -68.39 Million | -62.57 Million |
| Depreciation & Amortization | 93.19 Million | 5.58 Million | 5.32 Million | 62.91 Million | 4.37 Million | 4.77 Million |
| Deferred income taxes | -4.82 Million | - | - | -8.75 Million | - | - |
| Stock-based compensation | 31.5 Million | - | - | 22.1 Million | - | - |
| Change in working capital | -9.14 Million | - | - | 104.41 Million | - | - |
| Other non-cash items | 96.05 Million | 27.08 Million | 2.36 Million | 52.58 Million | 23.58 Million | 12.78 Million |
| Investing Cash Flow | 21.92 Million | 12.34 Million | -7.86 Million | -384.61 Million | -33.2 Million | -21.93 Million |
| Investments in PPE | -56.84 Million | -2.82 Million | -5.01 Million | -236.96 Million | -11.63 Million | -22.29 Million |
| Acquisitions | -20 Million | -2.83 Million | 1.48 Million | -20 Million | -2.89 Million | 361.67 Thousand |
| Investment purchases | - | 4.34 Million | -4.32 Million | -130 Million | -18.67 Million | - |
| Sales/Maturities of investments | - | 13.65 Million | - | 33.67 Million | - | - |
| Other Investing Activities | 98.76 Million | -1.00 | - | -31.32 Million | -2.00 | 1.00 |
| Financing Cash Flow | 368.75 Million | -10 Million | 72.09 Million | 619.26 Million | 23.89 Million | 71.87 Million |
| Debt repayment | -956.09 Million | -16.4 Million | -16.7 Million | -54.5 Million | -28.63 Million | -72.86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.92 Million | -819.24 Thousand | - | -26.77 Million | -3.84 Million | - |
| Common Stock Issuance | 470.08 Million | -3.04 Million | 67.82 Million | 19 Thousand | 1801.65 | 923.03 |
| Other Financing Activities | 10.29 Million | -21.71 Million | 21.64 Million | 700.52 Million | -900.11 Thousand | - |
| Accounts receivables | -91.53 Million | - | - | -388 Thousand | - | - |
| Accounts payables | 91.53 Million | - | - | 388 Thousand | - | - |
| Inventory | -6.71 Million | - | - | -5.51 Million | - | - |
| Other working capital | -2.42 Million | - | - | 109.93 Million | - | - |
| Cash at beginning of period | 1.34 Billion | 217.66 Million | 195.78 Million | 1.7 Billion | 253.67 Million | 273.53 Million |
| Cash at end of period | 1.03 Billion | 149.78 Million | 217.66 Million | 1.34 Billion | 195.78 Million | 253.67 Million |
| Capital Expenditure | -56.84 Million | -2.82 Million | -5.01 Million | -236.96 Million | -11.63 Million | -22.29 Million |
| Effect of forex changes on cash | 27.81 Million | -19.34 Million | 18.65 Million | 58.01 Million | 602.65 Thousand | -15.23 Million |
| Net cash flow / Change in cash | -307.59 Million | -67.88 Million | 21.88 Million | -361.24 Million | -57.89 Million | -19.85 Million |
| Free Cash Flow | -782.92 Million | -53.7 Million | -66.02 Million | -890.87 Million | -60.81 Million | -76.85 Million |
CLV
CONFIPET
VDEVF
RCI
OXIHF
5988